Due to the multifactorial pathogenesis of sarcopenia, it is crucial to identify biomarkers that
are risk factors for sarcopenia, and which therefore have a prognostic function. Aim: This …

Sarcopenia remains one of the major pathological features of type 2 diabetes (T2D),
especially in older individuals. This condition describes gradual loss of muscle mass …

Background Sarcopenia, a loss of skeletal muscle mass or function, affects up to 50% of
patients with inflammatory bowel disease (IBD) and is associated with poor clinical …

(1) Background: The involvement of redox balance alterations and innate immunity is
suggested to play a key role in the pathogenesis of sarcopenia. This investigation aimed to …

Background The role of interleukins in sarcopenia development has been acknowledged,
yet the specifics of their involvement remain to be fully understood. This study aimed to …

Background Observational studies have documented increased serum IL-6 levels in elderly
individuals afflicted with sarcopenia. Nevertheless, the relationship between serum IL-6 …

(1) Background: Several studies have reported that handgrip strength (HGS) may be a sign
of lower cognitive performance. However, studies supporting an association between …

Several studies have found a correlation between inflammatory markers and sarcopenia;
however, limited research has been conducted on the Arabic population. Therefore, this …

Background As people age, physical impairments may have a deleterious role in skeletal
muscles. Sarcopenia Clinical Practice Guidelines 2017 and the European Working Group …

Aims Given that little is known about the effect of lower extremity function (LEF) on
cardiovascular disease (CVD) subsequent risk among older adults, the association between …